Short Interest in Endonovo Therapeutics, Inc. (OTCMKTS:ENDV) Grows By 54.8%

Endonovo Therapeutics, Inc. (OTCMKTS:ENDV) saw a large growth in short interest during the month of March. As of March 31st, there was short interest totalling 619,000 shares, a growth of 54.8% from the March 15th total of 400,000 shares. Approximately 0.1% of the shares of the stock are sold short. Based on an average daily volume of 86,162,100 shares, the short-interest ratio is presently 0.0 days.

Endonovo Therapeutics Trading Up 50.0 %

Shares of OTCMKTS:ENDV traded up $0.00 during midday trading on Friday, hitting $0.00. 2,600,000 shares of the stock were exchanged, compared to its average volume of 29,533,193. Endonovo Therapeutics has a 52-week low of $0.00 and a 52-week high of $0.00.

About Endonovo Therapeutics

Endonovo Therapeutics, Inc, a biotechnology company, develops, manufactures, and distributes non-invasive Electroceutical medical devices for regenerative medicine. The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of soft tissue injuries, chronic wounds, and post-operative pain and edema.